The GSK oncology products it has sold on to Novartis were worth approximately $2 billion in 2014, having posted a growth of around 32 per cent compared to the previous year.

GSK is fast becoming thought of as the UK’s other pharma company following Pascal Soriot's successful turnaround of AstraZeneca – but according to press reports some investors are losing ...

Chemical Engineering is concerned with the design and operation of processes which convert materials and energy into the higher value products we use every day. It understands the processes which ...